Literature DB >> 10323786

Probucol enhances selective uptake of HDL-associated cholesteryl esters in vitro by a scavenger receptor B-I-dependent mechanism.

F Rinninger1, N Wang, R Ramakrishnan, X C Jiang, A R Tall.   

Abstract

Recently, the class B, type I scavenger receptor (SR-BI) has been shown to mediate the selective uptake of high density lipoprotein (HDL) cholesteryl esters (CEs), ie, lipid uptake independent of HDL holoparticle uptake. In vivo, this selective uptake delivers CEs to the liver for excretion and to steroidogenic tissues for hormone synthesis. Probucol, a hydrophobic antioxidant drug, lowers plasma cholesterol in humans and rodents and may inhibit progression of atherosclerosis and postangioplasty restenosis. In this study, the effect of probucol on HDL selective CE uptake was investigated in mice and in cells expressing SR-BI. Probucol feeding lowered plasma HDL cholesterol and markedly increased selective CE uptake from HDL in the liver and adrenal glands. However, probucol did not alter SR-BI protein levels in membranes from these organs. When incubated with control Chinese hamster ovary (CHO) cells, HDL isolated from probucol-treated mice (P-HDL) and HDL from control mice (C-HDL) showed similar low selective uptake of CEs. However, when incubated with SR-BI-transfected CHO cells, P-HDL showed a 2-fold increase in selective uptake compared with C-HDL. In an adrenal cell line (Y1-BS1), which expresses SR-BI in an adrenocorticotropic hormone-inducible manner, P-HDL showed significantly greater selective CE uptake than did C-HDL, and the differential response was amplified by adrenocorticotropic hormone treatment. In contrast to P-HDL, incorporation of this compound into HDL in vitro did not result in stimulation of selective CE uptake by SR-BI-transfected CHO cells, even though a significant mass of probucol could be detected in the HDL preparation. The specific interaction of P-HDL with SR-BI in cell culture could be observed after only 24 hours of probucol feeding, when there were minimal changes in HDL size and composition. Thus, probucol or one of its metabolites increases selective CE uptake in vivo by modifying HDL in a way that causes enhanced interaction with SR-BI. The increased interaction of P-HDL with SR-BI in the liver and arterial wall may be partly responsible for the effects of probucol on atherosclerosis and restenosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10323786     DOI: 10.1161/01.atv.19.5.1325

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  11 in total

1.  The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects.

Authors:  Armin Mooranian; Rebecca Negrulj; Ryu Takechi; John Mamo; Hesham Al-Sallami; Hani Al-Salami
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

2.  Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice.

Authors:  H E Miettinen; H Rayburn; M Krieger
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

3.  Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor.

Authors:  Alexander C Bashore; Mingxia Liu; Chia-Chi C Key; Elena Boudyguina; Xianfeng Wang; Caitlin M Carroll; Janet K Sawyer; Adam E Mullick; Richard G Lee; Shannon L Macauley; John S Parks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-06-06       Impact factor: 8.311

4.  Effect of anti-hyperlipidemia drugs on the alpha-tocopherol concentration and their potential for murine malaria infection.

Authors:  Aiko Kume; Maria Shirley Herbas; Mototada Shichiri; Noriko Ishida; Hiroshi Suzuki
Journal:  Parasitol Res       Date:  2015-09-11       Impact factor: 2.289

5.  Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport.

Authors:  Shigenori Yamamoto; Hiroyuki Tanigawa; Xiaoyu Li; Yohei Komaru; Jeffrey T Billheimer; Daniel J Rader
Journal:  Circulation       Date:  2011-08-22       Impact factor: 29.690

Review 6.  Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins.

Authors:  Baiba K Gillard; Corina Rosales; Bingqing Xu; Antonio M Gotto; Henry J Pownall
Journal:  J Clin Lipidol       Date:  2018-04-12       Impact factor: 4.766

Review 7.  Current, new and future treatments in dyslipidaemia and atherosclerosis.

Authors:  P H Chong; B S Bachenheimer
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

8.  Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis.

Authors:  Reijiro Arakawa; Maki Tsujita; Noriyuki Iwamoto; Chisato Ito-Ohsumi; Rui Lu; Chen-Ai Wu; Kenji Shimizu; Tomoji Aotsuka; Hashime Kanazawa; Sumiko Abe-Dohmae; Shinji Yokoyama
Journal:  J Lipid Res       Date:  2009-05-20       Impact factor: 5.922

9.  Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study.

Authors:  Armin Mooranian; Susbin Raj Wagle; Bozica Kovacevic; Ryu Takechi; John Mamo; Virginie Lam; Gerald F Watts; Momir Mikov; Svetlana Golocorbin-Kon; Goran Stojanovic; Hesham Al-Sallami; Hani Al-Salami
Journal:  Sci Rep       Date:  2020-01-09       Impact factor: 4.379

10.  Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits.

Authors:  Manabu Niimi; Yuka Keyamura; Masanori Nozako; Takashi Koyama; Masayuki Kohashi; Reiko Yasufuku; Tomohiro Yoshikawa; Jianglin Fan
Journal:  Lipids Health Dis       Date:  2013-11-04       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.